Since its founding in 2007, BioMentor's clients include both large publicly-held companies such as: Stryker Corp., LIVA NOVA, emerging to mature firms: NxStage Medical, Stentys, Jarvik Heart Inc., Penumbra Inc., NinePoint Medical, Avantis Medical, Corindus Inc., and fast-paced start-ups that have recently been acquired: BARRX Medical, Navilyst Medical, Advanced Bionics, Alphatec Spine International, Thoratec, Given Imaging, BionX Medical, DFINE Inc., and Xlumena.
BioMentor has also guided start-up firms such as: Stroma Medical, Neotract, Devicare (Spain), EKKYO (France), and Haptica (Ireland).
References available upon request.
President and CEO Jim Means most recently served as a vice president and general manager of Boston Scientific, a Boston based medical devices company, where he pioneered and developed direct sales subsidiaries in 14 locations around the world including Latin America, Central Europe, and The Middle East, overseeing $54 million in sales responsibilities. He was promoted, in May of 2005, to vice president-international of Boston Scientific's newly acquired company, Advanced Bionics. From 1983-1996 Means was international vice president of Nova Biomedical Corporation, where he established the international sales organization and grew the initial contribution from $1.5 million to $40 million. When not guiding businesses to international success, Means is passionate about skiing, tennis and ice hockey, as well as hiking, canoeing and kayaking. He has raced in the annual Run of the Charles canoe race in Boston every year since its inception 25 years ago. He is a connoisseur of fine food and wine and an avid supporter of the arts. Means is a sought after voice on the lecture circuit, has mentored MBA student candidates at Boston College, Boston University, and Babson College, and is an active and committed member of Rotary International. Means is a graduate of DePauw University (BA).